Conshohocken, PA, United States of America

Christine Ng Di Marco

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Ng Di Marco. Retrieved from https://idiyas.com/inventor/christine-ng-di-marco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Ng Di Marco: Innovator in HIV Treatment

Introduction

Christine Ng Di Marco is a notable inventor based in Conshohocken, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target HIV.

Latest Patents

Christine holds a patent for "Spirocyclic heterocycle compounds useful as HIV integrase inhibitors." This invention relates to Spirocyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts thereof. The patent also encompasses compositions that include at least one Spirocyclic Heterocycle Compound, along with methods for using these compounds to treat or prevent HIV infection in a subject.

Career Highlights

Christine is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing fight against HIV, showcasing her dedication to improving public health.

Collaborations

Christine has collaborated with esteemed colleagues such as Thomas H Graham and Wensheng Liu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Christine Ng Di Marco exemplifies the spirit of innovation in the pharmaceutical industry, with her groundbreaking work on HIV treatment. Her contributions are vital in the quest for effective therapies against this global health challenge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…